Efficacy of Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Richter Transformation: Results from the Phase 1/2 BRUIN Study
William G. Wierda,David John Lewis,Paolo Ghia,Nirav N. Shah,Catherine C. Coombs,Chan Y. Cheah,Nicole Lamanna,Joanna Rhodes,Marc Hoffmann,Shuo Ma,Toby A. Eyre,Talha Munir,Manish R. Patel,Alvaro J. Alencar,Constantine S. Tam,John F. Seymour,Wojciech Jurczak,Ewa Lech‐Marańda,Lindsey E. Roeker,Philip A. Thompson